Medscape

Experts Challenge FDA Approval of New Donepezil Dose

April 2, 2012 — Approval for the new 23-mg dose of the Alzheimer's disease (AD) drug donepezil (Aricept, Eisai) "breached the FDA's own regulatory standard" and has led to "incomplete and distorted ...
Medscape

FDA Approves High-Dose Donepezil for Advanced Alzheimer's Disease

July 27, 2010 — The US Food and Drug Administration (FDA) has approved donepezil HCl 23-mg tablets (Aricept; Eisai, Inc and Pfizer, Inc) for the once-daily treatment of moderate to severe Alzheimer's ...
Healio

Symptomatic Therapies

Cholinesterase inhibitors were the first agents specifically approved for Alzheimer’s disease (AD) management; the first AD drug from this class, tacrine, received FDA approval in 1993 but was ...
Nasdaq

Amneal Receives U.S. FDA Approval for Memantine/Donepezil Extended-Release Capsules and Everolimus Tablets for Oral Suspension, and Tentative U.S. FDA Approval for Rifaximin

BRIDGEWATER, N.J.--(BUSINESS WIRE)-- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Healthline

Your Guide to Treatment Medications for Alzheimer’s Disease

A variety of Alzheimer’s medications can help manage different symptoms and improve quality of life as the disease progresses. Alzheimer’s medications help manage symptoms by improving memory, ...